Wall Street Analysts Think Compass Therapeutics, Inc. (CMPX) Could Surge 134.14%: Read This Before Placing a Bet

Compass Therapeutics, Inc. (CMPX) closed the last trading session at $5.39, gaining 13% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 12.62 indicates a 134.1% upside potential.The mean estimate comprises 13 short-term price targets with a standard deviation of $6.67. While the lowest estimate of$ 8.00 indicates a 48.4% increase from the current price level, the most optimistic a ...